Hot Stocks For Today: Johnson & Johnson (JNJ), Aethlon Medical, Inc. (AEMD)

Share

The institutional investor owned 60,935 shares of the company's stock after selling 408 shares during the quarter.

The stock increased 1.44% or $0.66 during the last trading session, reaching $46.5.

Over the past five trading sessions shares of Aethlon Medical, Inc.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Benzinga.com which released: "Analyst: Morphosys Is Well-Positioned To Continue Success With Antibody Discovery Platforms" on May 14, 2018, also Livetradingnews.com with their article: "Johnson & Johnson (NYSE:JNJ) Heffx Technical Analysis" published on April 30, 2018, Seekingalpha.com published: "Novartis to initiate head-to-head study of Cosentyx versus J&J's Tremfya in patients with psoriatic plaques resistant to ..." on May 15, 2018. It has underperformed by 11.55% the S&P500.

Security National Trust Co decreased its stake in Johnson & Johnson (JNJ) by 16.44% based on its latest 2017Q4 regulatory filing with the SEC.

LePage, 6 other governors sign letter backing Trump for Nobel Peace Prize
The governors who signed the letter are Henry McMaster of South Carolina , Kay Ivey of Alabama, Jeff Colyer of Kansas, Paul R. LePage of Maine, Phil Bryant of Mississippi, Jim Justice of West Virginia, and Eddie Baza Calvo of the us territory of Guam.

In related news, VP Paulus Stoffels sold 155,342 shares of the company's stock in a transaction dated Thursday, February 15th. Investors who are keeping close eye on the stock of L Brands, Inc. About 5.72 million shares traded. JNJ underperformed by 10.43% the S&P500.

Since February 15, 2018, it had 0 buys, and 1 insider sale for $20.17 million activity. Oakbrook Invests Limited Liability Com stated it has 1.04% in Johnson & Johnson (NYSE:JNJ). The titles are as follows: "Johnson & Johnson: Steady As She Goes" released on April 19, 2018, "Johnson & Johnson (NYSE:JNJ) Stock Oversold" on May 03, 2018, "Analyst: Morphosys Is Well-Positioned To Continue Success With Antibody Discovery Platforms" with a publish date: May 14, 2018, "Johnson & Johnson Stock Looks Attractive on the Big Dip" and the last "Johnson & Johnson Sells Off After Earnings" with publication date: April 22, 2018. Therefore 50% are positive. Vetr raised Johnson & Johnson from a "hold" rating to a "buy" rating and set a $152.28 price objective for the company in a report on Tuesday, January 23rd.

Lord Abbett & Company, which manages about $35.15B US Long portfolio, decreased its stake in Dynavax Technologies Corp Com New (NASDAQ:DVAX) by 234,051 shares to 517,150 shares, valued at $9.67 million in 2017Q4, according to the filing. The stock has "Buy" rating by Argus Research on Wednesday, October 18. The company was downgraded on Friday, July 21 by Alembic. About 52,173 shares traded. Deutsche Bank maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, April 18 with "Buy" rating. Finally, Morgan Stanley reduced their price objective on Johnson & Johnson from $148.00 to $143.00 and set an "equal weight" rating for the company in a report on Tuesday, April 10th. Jefferies maintained the shares of JNJ in report on Tuesday, June 14 with "Hold" rating. The rating was upgraded by Barclays Capital on Tuesday, December 1 to "Overweight". Ls Inv Advisors Ltd Liability holds 0% or 452 shares in its portfolio. Shareholders of record on Tuesday, May 29th will be paid a $0.90 dividend. Its down 0.02, from 0.97 in 2017Q3.

At the end of 12/31/2017 reporting period, 1,202 institutional holders increased their position in Johnson & Johnson (NYSE:JNJ) by some 70,499,568 shares, 1,237 decreased positions by 47,964,095 and 221 held positions by 1,708,895,891. 143 funds bought holdings and 654 increased holdings. After this sale, 144,425 common shares of JNJ are directly owned by the insider, with total stake valued at $18,206,216. Franklin Res, a California-based fund reported 336,246 shares. Advisor Limited Liability Company invested 1.81% of its portfolio in Johnson & Johnson (NYSE:JNJ). Because all company has a different number of shares owned by the public, contrast only companies' earnings figures do not indicate how much money each company made for each of its shares, so we need E-P-S to make valid comparisons. 17 are the (NYSE:JNJ)'s analyst reports since January 2, 2018 according to StockzIntelligence Inc. It also increased its holding in Toll Brothers Inc (NYSE:TOL) by 780,000 shares in the quarter, for a total of 970,000 shares, and has risen its stake in Whirlpool Corp (NYSE:WHR). Trb Advisors Limited Partnership invested in 80,000 shs or 7.95% of the stock. Fcg Ltd Liability Corporation owns 1.97% invested in Johnson & Johnson (NYSE:JNJ) for 38,104 shares. Sandy Spring Bancorporation holds 2,383 shares. Mirador Prtn Lp accumulated 8,026 shares. (NYSEAMERICAN:LBY). 881,737 were accumulated by Spitfire Capital. Lincoln owns 61,231 shares. Albion Fincl Gru Ut invested in 0.57% or 26,865 shares. ORHub, Inc. (OTCMKTS:ORHB) has 0.00% since May 15, 2017 and is. Schroepfer Michael Todd had sold 26,940 shares worth $4.82M. FISCHER DAVID B. sold 17,830 shares worth $3.29 million. TheStreet downgraded Johnson & Johnson from an "a" rating to a "c+" rating in a research report on Monday, March 26th. Therefore 0 are positive. Seacor Holdings had 9 analyst reports since August 24, 2016 according to SRatingsIntel. As per Friday, April 27, the company rating was maintained by Williams Capital Group. Also, there are 2 buy, 0 sell and 2 strong sell ratings, collectively assigning a 2.22 average brokerage recommendation. The firm has "Buy" rating by Jefferies given on Thursday, November 5. The stock of Facebook, Inc. Stifel Nicolaus maintained Seacor Holdings Inc. Acumen Capital has "Buy" rating and $48.90 target. RBC Capital Markets maintained Stella-Jones Inc. (TSE:SJ) on Monday, April 3 with "Sector Perform" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Share